UBS Downgrades Ambev to Sell Citing Overvaluation

Ambev S.A. (ABEV) experienced downward price pressure during Thursday's trading session after UBS shifted its rating on the beverage giant from Neutral to Sell. The move reflects growing concerns among analysts regarding the company's current market pricing. The downgrade comes as a reaction to a significant price surge, with the stock having rallied 32% recently. UBS analysts believe the current market price no longer aligns with the company's fundamental value, suggesting that the rally has overextended the stock. Analyst Rodrigo Alcantara and his team noted that the risk-reward profile for ABEV is now skewed to the downside. The firm's assessment indicates that the recent gains have left the stock vulnerable to a correction as the valuation becomes difficult to justify. The market reaction was immediate, with shares slipping in afternoon trading as investors digested the warning regarding the company's valuation and the shift in sentiment from one of the world's largest investment banks.